Subjects: H.R.6331 — 111th Congress (2009-2010)

  • Administrative law and regulatory procedures
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Food and Drug Administration (FDA)
  • Health
  • Infectious and parasitic diseases
  • Intellectual property
  • Medical research
  • Medical tests and diagnostic methods
  • Prescription drugs